Integrating Machine Learning with Metabolic Models for Precision Trauma Care: Personalized ENDOTYPE Stratification and Metabolic Target Identification

preprint OA: closed CC-BY-4.0
Full text 24,645 characters · extracted from preprint-html · click to expand
Integrating Machine Learning with Metabolic Models for Precision Trauma Care: Personalized ENDOTYPE Stratification and Metabolic Target Identification | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Integrating Machine Learning with Metabolic Models for Precision Trauma Care: Personalized ENDOTYPE Stratification and Metabolic Target Identification Igor Marin de Mas, Lincoln Moura, Fernando Luiz Marcelo Antunes, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6258357/v2 This work is licensed under a CC BY 4.0 License Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Abstract Purpose : The pipeline developed here, utilizes the metabolic flux characterization of trauma patients as input for a computational framework, amalgamating various machine learning (ML) techniques. This pipeline enables the stratification of trauma patients into ENDOTYPES and pinpoint key metabolic targets associated with patient-specific ENDOTYPES. Previous studies have identified four distinct ENDOTYPES based on metabolic profiling in blood samples from patients in the context of Shock induced endotheliopathy (SHINE). These ENDOTYPES, labeled A, B, C, and D, exhibited notable differences in mortality ratios in a cohort of trauma patients, independent of injury severity. The endothelium, which is a tissue in direct contact with blood, plays a pivotal role in the composition of blood, thus impacting endothelial metabolism and consequently pathology. To address this, we developed an innovative approach combining genome-scale metabolic models and patients' plasma metabolomics. Although this methodology yields significant correlations between endothelial metabolic functions and mortality rates in ENDOTYPES, classical linear multivariate techniques did not uncover individual patient correlations, suggesting a complex, nonlinear relationship. To overcome this limitation, we have developed a novel computational approach that merges machine learning techniques with mechanistic modeling to stratify trauma patients into ENDOTYPES and identify patient-specific metabolic mechanisms associated with this pathology as potential therapeutic targets. Methods : The proposed pipeline begins with the application of our in-house mechanistic modeling method developed by Silva-Lance et al. (2024). This method integrates patients' plasma metabolome data with genome-scale metabolic models, serving as a data augmentation technique. It generates a cubic matrix that encapsulates the diverse metabolic flux profiles characterizing each patient. The pipeline then follows a series of steps: i.Preprocessing: Noise reduction, sparsity alleviation, outlier treatment, and numerical stability enhancement. ii.Dimension Reduction: Principal Component Analysis (PCA) is applied to distill essential features from the high-dimensional data. iii.Classification: A machine learning ensemble technique, the Gradient Boosting (GB) Algorithm, is employed for data classification. Finally, the Shapley Additive Explanation (SHAP) method, a game theory-based approach, is utilized to identify key metabolic reactions linked to distinct ENDOTYPES. These findings hold potential for guiding therapeutic applications. Results : The modeling-based data augmentation technique generated a cubic matrix encompassing 95 patients, each characterized by 3,006 metabolic reactions and 18,036 sampled solutions, totaling over five billion data points. Through preprocessing and dimensionality reduction, this matrix was condensed to 3% of its original size, retaining 2,656 reactions and 600 components for the 95 patients. This reduced dataset was used to train a robust GB model, achieving exceptional accuracy above 99.99% in stratifying patients by ENDOTYPES. SHAP analysis of the model revealed key mechanisms underlying patient classification, identifying critical reactions, genes, and pathways as potential therapeutic targets for personalized treatments. Among these, amino acid and fatty acid metabolism emerged as the most significant processes. Specific metabolites, such as amino acids, sphingosine, and melatonin, were identified as essential for ENDOTYPE stratification. Additionally, the dopamine receptor D1 (DRD1), a gene involved in amino acid transport, was highlighted as the most significant genetic factor. Notably, a group of seven metabolic reactions was found to act as a "switch," regulating the classification of patients between groups A and D, which exhibit the lowest and highest mortality rates, respectively. Low activity in these reactions was incompatible with the group A phenotype, favoring group D, while high activity produced the opposite effect. To evaluate their importance, a GB model trained solely on these seven reactions (representing 0.0077% of the original dataset) achieved a substantial accuracy of 78%, underscoring their role in modulating endothelial responses to trauma in the SHINE context. Interestingly, the dysregulation of all seven reactions contributes to either increased production of reactive oxygen species (ROS) or reduced ROS detoxification capabilities. This convergence leads to elevated levels of ROS in patients with ENDOTYPE D, aligning with clinical observations noted in the context of SHINE. A simulated treatment targeting the group of seven metabolic reactions in patients with ENDOTYPE D resulted in an average reduction in the expected mortality rate of 18.5%. Additionally, using the top 50 most critical reactions, a reduced version of the GB model was developed, achieving accuracies exceeding 99.99%. These streamlined models are more computationally efficient, making them highly suitable for implementation in low-cost, portable clinical devices, facilitating their integration into routine medical practice. Conclusion : This methodology has potential applications beyond trauma care, including cancer and cardiovascular diseases, where patient heterogeneity is crucial. By integrating GEMs with machine learning, it creates a framework for understanding complex diseases such as sepsis, cancer, ... and offers a platform for precision medicine and personalized therapies. Biological sciences/Computational biology and bioinformatics/Predictive medicine Biological sciences/Computational biology and bioinformatics/Biochemical reaction networks Biological sciences/Computational biology and bioinformatics/Machine learning Health sciences/Diseases/Trauma Health sciences/Molecular medicine Precision Medicine Machine Learning Metabolic Modeling Trauma Endotypes Full Text Additional Declarations The authors declare no competing interests. Supplementary Files MarindeMasetalSupplementaryMaterial1.xlsx Supplementary Material 1 MarindeMasetalSupplementaryMaterial2.xlsx Supplementary Material 2 MarindeMasetalSupplementarymaterial3.pdf Supplementary material 3 MarindeMasetalSupplementarymaterial4.pdf Supplementary material 4 MarindeMasetalSupplementarymaterial5.xlsx Supplementary material 5 MarindeMasetalSupplementarymaterial6.pdf Supplementary material 6 Cite Share Download PDF Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6258357","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":434590434,"identity":"2a678655-b4a8-4f4a-a37e-a2c264382368","order_by":0,"name":"Igor Marin de Mas","email":"data:image/png;base64,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","orcid":"","institution":"Copenhagen University Hospital, Righospitalet","correspondingAuthor":true,"prefix":"","firstName":"Igor","middleName":"Marin","lastName":"de Mas","suffix":""},{"id":434590435,"identity":"679e33c2-908d-48ad-ad60-9e0442218d53","order_by":1,"name":"Lincoln Moura","email":"","orcid":"","institution":"Universidade Federal do Ceará","correspondingAuthor":false,"prefix":"","firstName":"Lincoln","middleName":"","lastName":"Moura","suffix":""},{"id":434590436,"identity":"4d035586-66a7-43bd-9135-d3cddaef3e2f","order_by":2,"name":"Fernando Luiz Marcelo Antunes","email":"","orcid":"","institution":"Universidade Federal do Ceará","correspondingAuthor":false,"prefix":"","firstName":"Fernando","middleName":"Luiz Marcelo","lastName":"Antunes","suffix":""},{"id":434590438,"identity":"5cc783ce-05df-45bb-890c-1b3b39cb0c0d","order_by":3,"name":"Pär Ingemar Johansson","email":"","orcid":"","institution":"Copenhagen University Hospital, Righospitalet","correspondingAuthor":false,"prefix":"","firstName":"Pär","middleName":"Ingemar","lastName":"Johansson","suffix":""}],"badges":[],"createdAt":"2025-03-19 06:10:55","currentVersionCode":2,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-6258357/v2","doiUrl":"https://doi.org/10.21203/rs.3.rs-6258357/v2","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":84427103,"identity":"6a75bac0-bfa3-42c0-91eb-f12a8becc537","added_by":"auto","created_at":"2025-06-11 20:31:39","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":5788711,"visible":true,"origin":"","legend":"","description":"","filename":"MarindeMasetalMaintext.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2_covered_899284d5-8b24-42e9-b813-628a1d6eb7f6.pdf"},{"id":84426130,"identity":"a0a13b41-aca9-4a1e-90aa-19528e1795bd","added_by":"auto","created_at":"2025-06-11 20:07:20","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":356686,"visible":true,"origin":"","legend":"Supplementary Material 1","description":"","filename":"MarindeMasetalSupplementaryMaterial1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/c7db5bbb992dfea2412e9d65.xlsx"},{"id":84426129,"identity":"21616468-2293-483f-9f00-841917f5eab1","added_by":"auto","created_at":"2025-06-11 20:07:20","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":37015,"visible":true,"origin":"","legend":"Supplementary Material 2","description":"","filename":"MarindeMasetalSupplementaryMaterial2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/ce3a06f0d6f1a3676ced0fea.xlsx"},{"id":84426513,"identity":"9b59fe36-a451-440a-a096-42ff8f767225","added_by":"auto","created_at":"2025-06-11 20:15:20","extension":"pdf","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":1837985,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary material 3\u003c/p\u003e","description":"","filename":"MarindeMasetalSupplementarymaterial3.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/ba91106b77ae165a3f4c2184.pdf"},{"id":84426132,"identity":"0a2f2454-9ef9-417b-9f70-f4faed1cea70","added_by":"auto","created_at":"2025-06-11 20:07:20","extension":"pdf","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":101974,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary material 4\u003c/p\u003e","description":"","filename":"MarindeMasetalSupplementarymaterial4.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/5b429253384f017336caa47d.pdf"},{"id":84426134,"identity":"c8da00d5-f841-4bc5-ab84-9f054876b924","added_by":"auto","created_at":"2025-06-11 20:07:20","extension":"xlsx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":396443,"visible":true,"origin":"","legend":"Supplementary material 5","description":"","filename":"MarindeMasetalSupplementarymaterial5.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/d126fac56c7f2a383cf1179b.xlsx"},{"id":84426141,"identity":"3315bec3-c60f-48a2-80ae-fe4c1c3c5d51","added_by":"auto","created_at":"2025-06-11 20:07:21","extension":"pdf","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":8218007,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary material 6\u003c/p\u003e","description":"","filename":"MarindeMasetalSupplementarymaterial6.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6258357/v2/03a22a74e167ba36ae3c0354.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"Integrating Machine Learning with Metabolic Models for Precision Trauma Care: Personalized ENDOTYPE Stratification and Metabolic Target Identification","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Precision Medicine, Machine Learning, Metabolic Modeling, Trauma Endotypes","lastPublishedDoi":"10.21203/rs.3.rs-6258357/v2","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6258357/v2","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003ePurpose\u003c/strong\u003e: The pipeline developed here, utilizes the metabolic flux characterization of trauma patients as input for a computational framework, amalgamating various machine learning (ML) techniques. This pipeline enables the stratification of trauma patients into ENDOTYPES and pinpoint key metabolic targets associated with patient-specific ENDOTYPES. Previous studies have identified four distinct ENDOTYPES based on metabolic profiling in blood samples from patients in the context of Shock induced endotheliopathy (SHINE). These ENDOTYPES, labeled A, B, C, and D, exhibited notable differences in mortality ratios in a cohort of trauma patients, independent of injury severity. The endothelium, which is a tissue in direct contact with blood, plays a pivotal role in the composition of blood, thus impacting endothelial metabolism and consequently pathology. To address this, we developed an innovative approach combining genome-scale metabolic models and patients' plasma metabolomics. Although this methodology yields significant correlations between endothelial metabolic functions and mortality rates in ENDOTYPES, classical linear multivariate techniques did not uncover individual patient correlations, suggesting a complex, nonlinear relationship. To overcome this limitation, we have developed a novel computational approach that merges machine learning techniques with mechanistic modeling to stratify trauma patients into ENDOTYPES and identify patient-specific metabolic mechanisms associated with this pathology as potential therapeutic targets.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods\u003c/strong\u003e: The proposed pipeline begins with the application of our in-house mechanistic modeling method developed by Silva-Lance et al. (2024). This method integrates patients' plasma metabolome data with genome-scale metabolic models, serving as a data augmentation technique. It generates a cubic matrix that encapsulates the diverse metabolic flux profiles characterizing each patient. The pipeline then follows a series of steps: i.Preprocessing: Noise reduction, sparsity alleviation, outlier treatment, and numerical stability enhancement. ii.Dimension Reduction: Principal Component Analysis (PCA) is applied to distill essential features from the high-dimensional data. iii.Classification: A machine learning ensemble technique, the Gradient Boosting (GB) Algorithm, is employed for data classification. Finally, the Shapley Additive Explanation (SHAP) method, a game theory-based approach, is utilized to identify key metabolic reactions linked to distinct ENDOTYPES. These findings hold potential for guiding therapeutic applications.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e: The modeling-based data augmentation technique generated a cubic matrix encompassing 95 patients, each characterized by 3,006 metabolic reactions and 18,036 sampled solutions, totaling over five billion data points. Through preprocessing and dimensionality reduction, this matrix was condensed to 3% of its original size, retaining 2,656 reactions and 600 components for the 95 patients. This reduced dataset was used to train a robust GB model, achieving exceptional accuracy above 99.99% in stratifying patients by ENDOTYPES. SHAP analysis of the model revealed key mechanisms underlying patient classification, identifying critical reactions, genes, and pathways as potential therapeutic targets for personalized treatments. Among these, amino acid and fatty acid metabolism emerged as the most significant processes. Specific metabolites, such as amino acids, sphingosine, and melatonin, were identified as essential for ENDOTYPE stratification. Additionally, the dopamine receptor D1 (DRD1), a gene involved in amino acid transport, was highlighted as the most significant genetic factor. Notably, a group of seven metabolic reactions was found to act as a \"switch,\" regulating the classification of patients between groups A and D, which exhibit the lowest and highest mortality rates, respectively. Low activity in these reactions was incompatible with the group A phenotype, favoring group D, while high activity produced the opposite effect. To evaluate their importance, a GB model trained solely on these seven reactions (representing 0.0077% of the original dataset) achieved a substantial accuracy of 78%, underscoring their role in modulating endothelial responses to trauma in the SHINE context. Interestingly, the dysregulation of all seven reactions contributes to either increased production of reactive oxygen species (ROS) or reduced ROS detoxification capabilities. This convergence leads to elevated levels of ROS in patients with ENDOTYPE D, aligning with clinical observations noted in the context of SHINE. A simulated treatment targeting the group of seven metabolic reactions in patients with ENDOTYPE D resulted in an average reduction in the expected mortality rate of 18.5%. Additionally, using the top 50 most critical reactions, a reduced version of the GB model was developed, achieving accuracies exceeding 99.99%. These streamlined models are more computationally efficient, making them highly suitable for implementation in low-cost, portable clinical devices, facilitating their integration into routine medical practice.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e: This methodology has potential applications beyond trauma care, including cancer and cardiovascular diseases, where patient heterogeneity is crucial. By integrating GEMs with machine learning, it creates a framework for understanding complex diseases such as sepsis, cancer, ... and offers a platform for precision medicine and personalized therapies.\u003c/p\u003e","manuscriptTitle":"Integrating Machine Learning with Metabolic Models for Precision Trauma Care: Personalized ENDOTYPE Stratification and Metabolic Target Identification","msid":"","msnumber":"","nonDraftVersions":[{"code":2,"date":"2025-06-11 20:07:15","doi":"10.21203/rs.3.rs-6258357/v2","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}},{"code":1,"date":"2025-03-27 04:22:41","doi":"10.21203/rs.3.rs-6258357/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"9dcd6d6f-6d2e-41cd-b2fd-723a77b6dd89","owner":[],"postedDate":"June 11th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":46275223,"name":"Biological sciences/Computational biology and bioinformatics/Predictive medicine"},{"id":46275224,"name":"Biological sciences/Computational biology and bioinformatics/Biochemical reaction networks"},{"id":46275225,"name":"Biological sciences/Computational biology and bioinformatics/Machine learning"},{"id":46275226,"name":"Health sciences/Diseases/Trauma"},{"id":46275227,"name":"Health sciences/Molecular medicine"}],"tags":[],"updatedAt":"2025-04-08T14:10:31+00:00","versionOfRecord":[],"versionCreatedAt":"2025-06-11 20:07:15","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v2","identity":"rs-6258357","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6258357","identity":"rs-6258357","version":["v2"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-23T02:00:01.238055+00:00
License: CC-BY-4.0